Loading organizations...
Loading organizations...
Alveus Therapeutics has raised $554.0M across 4 funding rounds.
Alveus Therapeutics has raised $554.0M in total across 4 funding rounds.
Alveus Therapeutics has raised $554.0M in total across 4 funding rounds.
Alveus Therapeutics's investors include Andera Partners, New Rhein Healthcare Investors, Avego Bioscience Capital, Rafaèle Tordjman, Kurma Partners, Novo Holdings, Omega Funds, Sanofi Ventures, Jan Van den Bossche, Nayan Parekh, Claudio Nessi.
Alveus Therapeutics has raised $554.0M across 4 funding rounds. Most recently, it raised $197.0M Series A Extension in March 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 3, 2026 | $197.0M Series A Extension | Andera Partners, New Rhein Healthcare Investors | Avego Bioscience Capital, Rafaèle Tordjman, Kurma Partners, Novo Holdings, Omega Funds, Sanofi Ventures |
| Jan 8, 2026 | $160.0M Series A | Jan Van den Bossche, Nayan Parekh, Claudio Nessi | Avego Bioscience Capital, Kurma Partners, Sanofi Ventures |
| $197.0M Alveus Therapeutics Funding Round | New Rhein Healthcare Investors, Andera Partners | ||
| Alveus Therapeutics |